Cure My Disease

Don't miss your cure!

 Log in / Sign up

Extended trial tests new drug for rare hormone disorder

NCT ID NCT06712823

Recruiting now Disease control Sponsor: Crinetics Pharmaceuticals Inc. Source: ClinicalTrials.gov ↗

Summary

This study aims to learn about the long-term safety and effectiveness of the experimental drug atumelnant (CRN04894) for people with congenital adrenal hyperplasia (CAH), a rare genetic hormone condition. It is open to about 150 people who have already taken this drug in a previous Crinetics study and, in their doctor's opinion, could benefit from continuing it. The main goals are to monitor side effects and see how well the drug controls key hormone levels over an extended period.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONGENITAL ADRENAL HYPERPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Crinetics Study Site

    ACTIVE_NOT_RECRUITING

    Morehead City, North Carolina, 28557, United States

  • Crinetics Study Site

    RECRUITING

    Córdoba, Córdoba Province, 5000, Argentina

  • Crinetics Study Site

    RECRUITING

    Botucatu, São Paulo, 18618-686, Brazil

  • Crinetics Study Site

    RECRUITING

    São Paulo, 05403-000, Brazil

  • Crinetics Study Site

    RECRUITING

    Munich, Bavaria, 80336, Germany

  • Crinetics Study Site

    RECRUITING

    Roma, 00161, Italy

  • Crinetics Study Site

    RECRUITING

    Birmingham, CV22DX, United Kingdom

  • Crinetics Study Site

    RECRUITING

    London, NW1 2BU, United Kingdom

  • Crinetics Study Site, Minneapolis, Minnesota 55454

    ACTIVE_NOT_RECRUITING

    Minneapolis, Minnesota, 55455, United States

Conditions

Explore the condition pages connected to this study.

CLASSIC CONGENITAL ADRENAL HYPERPLASIA CONGENITAL ADRENAL HYPERPLASIA